Form D · Other

XOStem Biosciences Ltd.

Irvine, CA · CIK 0001814587

Offering snapshot reported Feb 29, 2024 · SEC filing

Reported sold
$378K
Offering amount: $756K
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 16, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 29, 2024Initial$378,000No comparison10SEC filing
Oct 11, 2023Initial$30,000No comparison1SEC filing
Aug 31, 2023Initial$785,500No comparison26SEC filing
Aug 30, 2023Initial$65,000No comparison3SEC filing
Apr 19, 2023Initial$587,000No comparison34SEC filing
Jan 23, 2023Initial$350,000No comparison3SEC filing
Nov 8, 2022Initial$892,000No comparison21SEC filing
Jun 16, 2020Initial$302,651No comparison8SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-506425
Total amount remaining represents amounts that may be received upon exercise of warrants

Source: Form D, filed Feb 29, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Brad Eckenweiler Director
Chad Friesen Director
Richard Johns Director, Executive
Jonathan Robert Todd Lakey Director, Executive
Alex Mc Aulay Director, Executive
John Sanderson Director, Executive
Gary Yeoman Director

Issuer details

Industry: Other (See others in industry)

Address:
18218 Mcdurmott East Suite A1
Irvine, CA, 92614